Senicapoc (ICA-17043) is a novel Gardos channel blocker. It is being investigated for the treatment of sickle cell disease.
Investigated for use/treatment in anemia (sickle cell) and asthma.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.